Osteo Bi-Flex
Osteo Bi-Flex Triple Strength
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
19
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
8 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Calories UNII · 1 | 10 Calorie(s) | — |
| Total Carbohydrates CarbohydrateUNII · 0 | 2 Gram(s) | 1% |
| Vitamin C UNII · PQ6CK8PD0R | 60 mg | 67% |
| Manganese UNII · 42Z2K6ZL8P | 2 mg | 87% |
| Sodium UNII · 9NEZ333N27 | 35 mg | 2% |
| Glucosamine Hydrochloride UNII · 750W5330FY | 1500 mg | — |
| Total Carbohydrates CarbohydrateUNII · 0 | 100 mg | — |
| Chondroitin/MSM Complex Blend (Combination) | 1103 mg | — |
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
19
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Crospovidone · Cellulose · Silica · Magnesium Stearate